Market Research Logo

China Pharmaceutical Manufacturing Industry, 2016

China Pharmaceutical Manufacturing Industry, 2016

China pharmaceutical manufacturing industry, 2016 is valuable for anyone who wants to invest in the pharmaceutical manufacturing industry, to get Chinese investments; to import into China or export from China, to build factories and take advantage of lower costs in China, to partner with one of the key Chinese corporations, to get market shares as China is boosting its domestic needs; to forecast the future of the world economy as China is leading the way; or to compete in the segment. The report provides the whole set of the industry data, in-depth analysis and detailed insight into the pharmaceutical manufacturing industry, market drivers, key enterprises and their strategies, as well as technologies and investment status, risks and trends.

Data sources: Governmental statistics organizations, market research (monitoring) centers, industry associations and institutions, import and export statistics organizations, and others.

There are 123 figures and tables in the report.

Knowledge is power. If you want to invest in, import into/from, partner with, or compete against any of the companies in this field, then China pharmaceutical manufacturing industry, 2016 is required reading.


Part I Industry Overview
1 Definition and development of pharmaceutical manufacturing industry
1.1 Definition of the industry and its core products
1.1.1 Definition of the industry
1.1.2 Core products
1.2 Main characteristics of the industry and a history of its development
1.2.1 Major characteristics of the industry
1.2.2 Course of industrial development
2 Macro environment and impact analysis of pharmaceutical manufacturing industry
2.1 Current macroeconomic developments and trends
2.1.1 China macroeconomic operating environment: 2014
2.1.2 Recommendation on related policies
2.2 Latest industry policies and related laws and regulations
2.3 Development of Upstream and Downstream Industries
2.3.1 Upstream industries
2.3.2 Downstream industries
3 International market analysis of pharmaceutical manufacturing industry
3.1 Current development of its international market
3.2 Levels of development in key countries and regions
3.2.1 United States
3.2.2 United Kingdom
4 Domestic market analysis of pharmaceutical manufacturing industry
4.1 Current development of its domestic market
4.2 Trends in the domestic market
Part 2 Basic indices
5 Size analysis of pharmaceutical manufacturing industry during 2008-2014
5.1 Enterprise number status: 2008-2014
5.2 Number of loss- making enterprises: 2008-2014
5.3 Total loss of the industry: 2008- 2014
5.4 Number of employees: 2008-2014
6 Asset analysis of pharmaceutical manufacturing industry during 2008-2014
6.1 Gross assets of the industry: 2008-2014
6.2 Status of fixed assets: 2008-2014
6.3 Current assets: 2007-2013
Part 3 Economic Operation
7 Gross industrial output value analysis of pharmaceutical manufacturing industry during 2008-2014
7.1 Gross industrial output value: 2008-2014
7.1.1 Overview
7.1.2 By scale
7.1.3 By ownership
7.2 Distribution of gross industrial output value by region: 2014
8 Sales revenue analysis of pharmaceutical manufacturing industry during 2008-2014
8.1 Total industry sales revenue: 2008-2014
8.1.1 Overview
8.1.2 By scale
8.1.3 By ownership
8.2 Distribution of sales revenue by region in 2014
9 Total profits analysis of pharmaceutical manufacturing industry during 2008-2014
9.1 Gross profit analysis: 2008-2014
9.1.1 Overview
9.1.2 By scale
9.1.3 By ownership
9.2 Distribution of total profits by region in 2014
10 Import and export analysis of pharmaceutical manufacturing industry in 2014
10.1 Total import and export analysis of the pharmaceutical manufacturing industry in 2014
10.2 Import and export country analysis of the pharmaceutical manufacturing industry in 2014
10.3 Import and export customs analysis of the pharmaceutical manufacturing industry in 2014
10.4 Import and export region analysis of the pharmaceutical manufacturing industry in 2014
Part 4: Competitive landscape
11 Competitive landscape analysis of pharmaceutical manufacturing industry
11.1 Competitive landscape in the regional markets
11.2 Market share of enterprises in the industry
12 Comparative analysis on the competitiveness of key enterprises in pharmaceutical manufacturing industry
12.1 Comparison for total assets of key enterprises
12.2 Comparison of the number of employees in the key enterprises in the industry
12.3 Comparison for annual operational revenue of key enterprises
12.4 Comparison for export delivery value of key enterprises
12.5 Comparison for total profits of key enterprises
12.6 Comparison for competitiveness of key enterprises
Part 5 Key Enterprises
13 Comparative analysis on the economic indicators of key enterprises in pharmaceutical manufacturing industry
13.1 Yangtze River Pharmaceutical Group Co., Ltd
A Basic information
B Operating status analysis
C Assets and liabilities analysis
D Operating expense and cost analysis
13.2 Harbin Pharmaceutical Group Co., Ltd
A Basic information
B Analysis of enterprise’s business operation
C Assets and liabilities analysis
D Operating expense and cost analysis
13.3 Jilin Xiuzheng Pharmaceutical Group Co., Ltd
A Basic information
B Operating status analysis
C Assets and liabilities analysis
D Operating expense and cost analysis
13.4 CSPC Pharmaceutical Group Limited
A Basic information
B Operating status analysis
C Assets and liabilities analysis
D Operating expense and cost analysis
13.5 Weigao Holding Company Limited
A Basic information
B Operating status analysis
C Assets and liabilities analysis
D Operating expense and cost analysis
13.6 Northeast Pharmaceutical Group Co., Ltd
A Basic information
B Operating status analysis
C Assets and liabilities analysis
D Operating expense and cost analysis
13.7 Bayer HealthCare Co., Ltd
A Basic information
B Operating status analysis
C Assets and liabilities analysis
D Operating expense and cost analysis
13.8 North China Pharmaceutical Group Corp.
A Basic information
B Operating status analysis
C Assets and liabilities analysis
D Operating expense and cost analysis
13.9 Xinxiang Liuzhuang Agriculture- Industry-Commerce United Company
A Basic information
B Operating status analysis
C Assets and liabilities analysis
D Operating expense and cost analysis
13.10 Xi'an Janssen Pharmaceutical Ltd
A Basic information
B Operating status analysis
C Assets and liabilities analysis
D Operating expense and cost analysis
13.11 Henan Caixin Group Co., Ltd
A Basic information
B Operating status analysis
C Assets and liabilities analysis
D Operating expense and cost analysis
13.12 Yishui Dadi Corn Developing Co., Ltd
A Basic information
B Analysis of enterprise’s business operation
C Assets and liabilities analysis
D Operating expense and cost analysis
13.13 Pfizer Pharmaceuticals Limited
A Basic information
B Operating status analysis
C Assets and liabilities analysis
D Operating expense and cost analysis
13.14 Novo Nordisk (China) Pharmaceuticals Co., Ltd
A Basic information
B Operating status analysis
C Assets and liabilities analysis
D Operating expense and cost analysis
13.15 Tianjin Zhongxin Pharmaceutical Group Corporation Limited
A Basic information
B Operating status analysis
C Assets and liabilities analysis
D Operating expense and cost analysis
13.16 Reyoung Pharmaceutical Co., Ltd
A Basic information
B Operating status analysis
C Assets and liabilities analysis
D Operating expense and cost analysis
13.17 Shijiazhuang PharmaGroup Zhongrun Pharmaceutical (Inner Mongolia) Co., ltd
A Basic information
B Operating status analysis
C Assets and liabilities analysis
D Operating expense and cost analysis
13.18 Shanghai Roche Pharmaceuticals Limited
A Basic information
B Analysis of enterprise’s business operation
C Assets and liabilities analysis
D Operating expense and cost analysis
13.19 Zhejiang Medicine Co., Ltd Xinchang Pharmaceutical Factory
A Basic information
B Operating status analysis
C Assets and liabilities analysis
D Operating expense and cost analysis
13.20 Huiren Group Co., Ltd
A Basic information
B Operating status analysis
C Assets and liabilities analysis
D Operating expense and cost analysis
Party 6 Operational Strategies
14 Development bottlenecks of the pharmaceutical manufacturing industry and counter strategies
14.1 Development bottleneck of the industry
14.2 Coping strategies of the industry
Part 7 Market Investment
15 Comparison and analysis of investment activity coefficients and investment returns of the pharmaceutical manufacturing industry
15.1 Activity coefficient comparison and analysis of the industry
15.1.1 Related industry activity coefficient comparison in 2014
15.1.2 Activity coefficient of the industry: 2008-2014
15.1.3 Views
15.2 Investment return comparison and analysis of the industry
15.2.1 Comparison of rate of return on investment in related industry: 2014
15.2.2 Analysis on industry rate of return from investment: 2008-2014
15.2.3 Views
16 Analysis of investment environment and investment risks of the pharmaceutical manufacturing industry
16.1 Investment environment of the industry
16.1.1 Financial barriers
16.1.2 Technical barriers
16.1.3 Patent barriers
16.2 Investment risks of the industry
16.2.1 Cyclical risks with new drug R&D
16.2.2 Technological risks with new drug R&D
16.2.3 Risks with industrial qualification and approval
16.3 Investment recommendations
Part 8 Processes and technologies
17 Current situation and trends of the newest technology applications in the pharmaceutical manufacturing industry
17.1 Application of the latest technologies in the industry
17.2 Technological development trend in the industry
Part 9 Development Trends
18 Development trends and operating capability forecast of the pharmaceutical manufacturing industry
18.1 Development trend of the industry
18.2 Industry operating capability forecast: 2015-2019
18.2.1 Total assets forecast: 2015-2019
18.2.2 Total industrial output value forecast of the industry: 2015-2019
18.2.3 Sales revenue forecast: 2015-2019
18.2.4 Total revenue forecast: 2015-2019
List of Charts
Number of enterprises in the pharmaceutical manufacturing industry and year-on-year growth: 2008-2014
Number of loss-making enterprises in the pharmaceutical manufacturing industry and year-on-year growth: 2008-2014
Total losses of the pharmaceutical manufacturing industry and year-on-year growth: 2008-2014
Total number of employees in the pharmaceutical manufacturing industry and year-on-year growth: 2008-2014
Total assets of the pharmaceutical manufacturing industry and year-on-year growth: 2008-2014
Fixed assets in the pharmaceutical manufacturing industry: 2008-2014
Current assets of the pharmaceutical manufacturing industry and year-on-year growth: 2008-2014
Total industrial output value of the pharmaceutical manufacturing industry and year-on-year growth: 2008-2014
Gross industrial output value of enterprises in the pharmaceutical manufacturing industry by size: 2008-2014
Gross industrial output value of enterprises in the pharmaceutical manufacturing industry by ownership: 2008-2014
Gross industrial output value in the pharmaceutical manufacturing industry by region in 2014
Sales revenue of the pharmaceutical manufacturing industry and year-on-year growth: 2008-2014
Sales revenue of enterprises in the pharmaceutical manufacturing industry by size: 2008-2014
Sales revenue of enterprises in the pharmaceutical manufacturing industry by ownership: 2008-2014
Sales revenue in the pharmaceutical manufacturing industry by region in 2014
Total profits of the pharmaceutical manufacturing industry and year-on-year growth: 2008-2014
Total profits of enterprises in the pharmaceutical manufacturing industry by size: 2008-2014
Total profits of enterprises in the pharmaceutical manufacturing industry by ownership: 2008-2014
Total profits in the pharmaceutical manufacturing industry by region in 2014
Total import of the pharmaceutical manufacturing industry: 2014
Total export of the pharmaceutical manufacturing industry in 2014
Distribution of importing countries in the pharmaceutical manufacturing industry: 2014
Distribution of exporting countries in the pharmaceutical manufacturing industry: 2014
Importing customs of the pharmaceutical manufacturing industry: 2014
Exporting customs of the pharmaceutical manufacturing industry: 2014
Importing regions of the pharmaceutical manufacturing industry: 2014
Exporting regions of the pharmaceutical manufacturing industry: 2014
Competitive landscape of the pharmaceutical manufacturing industry by region
Market share comparison for enterprises in the industry
Total assets comparison for key enterprises in the industry
Comparison for number of employees in key enterprises in the industry
Annual operating revenue comparison for key enterprises in the industry
Output delivery value comparison for key enterprises in the industry
Total profits comparison for key enterprises in the industry
Comprehensive competitiveness comparison for key enterprises in the industry
General information about Yangtze River Pharmaceutical Group Co., Ltd
Analysis of business performance of Yangtze River Pharmaceutical Group Co., Ltd
Analysis of liabilities of Yangtze River Pharmaceutical Group Co., Ltd
Analysis of operating expenses and costs of Yangtze River Pharmaceutical Group Co., Ltd
General information about Harbin Pharmaceutical Group Co., Ltd
Analysis of business performance of Harbin Pharmaceutical Group Co., Ltd
Analysis of liabilities of Harbin Pharmaceutical Group Co., Ltd
Analysis of operating expenses and costs of Harbin Pharmaceutical Group Co., Ltd
General information about Jilin Xiuzheng Pharmaceutical Group Co., Ltd
Analysis of business performance of Jilin Xiuzheng Pharmaceutical Group Co., Ltd
Analysis of liabilities of Jilin Xiuzheng Pharmaceutical Group Co., Ltd
Analysis of operating expenses and costs of Jilin Xiuzheng Pharmaceutical Group Co., Ltd
General information about CSPC Pharmaceutical Group Limited
Analysis of business performance of CSPC Pharmaceutical Group Limited
Analysis of liabilities of CSPC Pharmaceutical Group Limited
Analysis of operating expenses and costs of CSPC Pharmaceutical Group Limited
General information about Weigao Holding Company Limited
Analysis of business performance of Weigao Holding Company Limited
Analysis of liabilities of Weigao Holding Company Limited
Analysis of operating expenses and costs of Weigao Holding Company Limited
General information about Northeast Pharmaceutical Group Co., Ltd
Analysis of business performance of Northeast Pharmaceutical Group Co., Ltd
Analysis of liabilities of Northeast Pharmaceutical Group Co., Ltd
Analysis of operating expenses and costs of Northeast Pharmaceutical Group Co., Ltd
General information about Bayer HealthCare Co., Ltd
Analysis of business performance of Bayer HealthCare Co., Ltd
Analysis of liabilities of Bayer HealthCare Co., Ltd
Analysis of operating expenses and costs of Bayer HealthCare Co., Ltd
General information about North China Pharmaceutical Group Corp.
Analysis of business performance of North China Pharmaceutical Group Corp.
Analysis of liabilities of North China Pharmaceutical Group Corp.
Analysis of operating expenses and costs of North China Pharmaceutical Group Corp.
General information about Xinxiang Liuzhuang Agriculture- Industry-Commerce United Company
Analysis of business performance of Xinxiang Liuzhuang Agriculture- Industry-Commerce United Company
Analysis of liabilities of Xinxiang Liuzhuang Agriculture- Industry-Commerce United Company
Analysis of operating expenses and costs of Xinxiang Liuzhuang Agriculture- Industry-Commerce United Company
General information about Xi'an Janssen Pharmaceutical Ltd
Analysis of business performance of Xi'an Janssen Pharmaceutical Ltd
Analysis of liabilities of Xi'an Janssen Pharmaceutical Ltd
Analysis of operating expenses and costs of Xi'an Janssen Pharmaceutical Ltd
General information about Henan Caixin Group Co., Ltd
Analysis of business performance of Henan Caixin Group Co., Ltd
Analysis of liabilities of Henan Caixin Group Co., Ltd
Analysis of operating expenses and costs of Henan Caixin Group Co., Ltd
General information about Yishui Dadi Corn Developing Co., Ltd
Analysis of business performance of Yishui Dadi Corn Developing Co., Ltd
Analysis of liabilities of Yishui Dadi Corn Developing Co., Ltd
Analysis of operating expenses and costs of Yishui Dadi Corn Developing Co., Ltd
General information about Pfizer Pharmaceuticals Limited
Analysis of business performance of Pfizer Pharmaceuticals Limited
Analysis of liabilities of Pfizer Pharmaceuticals Limited
Analysis of operating expenses and costs of Pfizer Pharmaceuticals Limited
General information about Novo Nordisk (China) Pharmaceuticals Co., Ltd
Analysis of business performance of Novo Nordisk (China) Pharmaceuticals Co., Ltd
Analysis of liabilities of Novo Nordisk (China) Pharmaceuticals Co., Ltd
Analysis of operating expenses and costs of Novo Nordisk (China) Pharmaceuticals Co., Ltd
General information about Tianjin Zhongxin Pharmaceutical Group Corporation Limited
Analysis of business performance of Tianjin Zhongxin Pharmaceutical Group Corporation Limited
Analysis of liabilities of Tianjin Zhongxin Pharmaceutical Group Corporation Limited
Analysis of operating expenses and costs of Tianjin Zhongxin Pharmaceutical Group Corporation Limited
General information about Reyoung Pharmaceutical Co., Ltd
Analysis of business performance of Reyoung Pharmaceutical Co., Ltd
Analysis of liabilities of Reyoung Pharmaceutical Co., Ltd
Analysis of operating expenses and costs of Reyoung Pharmaceutical Co., Ltd
General information about Shijiazhuang PharmaGroup Zhongrun Pharmaceutical (Inner Mongolia) Co., ltd
Analysis of business performance of Shijiazhuang PharmaGroup Zhongrun Pharmaceutical (Inner Mongolia) Co., ltd
Analysis of liabilities of Shijiazhuang PharmaGroup Zhongrun Pharmaceutical (Inner Mongolia) Co., ltd
Analysis of operating expenses and costs of Shijiazhuang PharmaGroup Zhongrun Pharmaceutical (Inner Mongolia) Co., ltd
General information about Shanghai Roche Pharmaceuticals Limited
Analysis of business performance of Shanghai Roche Pharmaceuticals Limited
Analysis of liabilities of Shanghai Roche Pharmaceuticals Limited
Analysis of operating expenses and costs of Shanghai Roche Pharmaceuticals Limited
General information about Zhejiang Medicine Co., Ltd Xinchang Pharmaceutical Factory
Analysis of business performance of Zhejiang Medicine Co., Ltd Xinchang Pharmaceutical Factory
Analysis of liabilities of Zhejiang Medicine Co., Ltd Xinchang Pharmaceutical Factory
Analysis of operating expenses and costs of Zhejiang Medicine Co., Ltd Xinchang Pharmaceutical Factory
General information about Huiren Group Co., Ltd
Analysis of business performance of Huiren Group Co., Ltd
Analysis of liabilities of Huiren Group Co., Ltd
Analysis of operating expenses and costs of Huiren Group Co., Ltd
Related industry activity coefficient comparison in 2014
Activity coefficient of the industry: 2008-2014
Comparison of related industries’ return on investment: 2014
Analysis on industry rate of return from investment: 2008-2014
Forecast of industry’s total assets: 2015-2019
Forecast of industry’s total industrial output value: 2015-2019
Forecast of industry’s sales revenue: 2015-2019
Total profits forecast for the industry: 2015-2019

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report